Blue Cross Laboratories Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 64.80 Cr
as on 16-06-2024
- Company Age 44 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.35 Cr
as on 16-06-2024
- Revenue 6.38%
(FY 2023)
- Profit 2.65%
(FY 2023)
- Ebitda 6.25%
(FY 2023)
- Net Worth 2.92%
(FY 2023)
- Total Assets 2.59%
(FY 2023)
About Blue Cross Laboratories
The Corporate was formerly known as Blue Cross Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 64.80 Cr.
The company has closed loans amounting to ₹10.35 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Blue Cross Laboratories Private Limited India are Suresh Mahalingam as COMPANY SECRETARY and Ketki Wadhawa as Cfo. Rohit Patel, Ashish Shirsat, Bhalchandra Govind, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1980PTC022825
- Company No.
022825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 1980
- Date of AGM
04 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Blue Cross Laboratories Private Limited offer?
Blue Cross Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antispasmodic Drugs, Gastrointestinal Drugs, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antibiotic Tablets, Capsule & Syrup, Cardiovascular Drugs & Medication, Kidney Drugs, Antibacterial Drugs, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Blue Cross Laboratories?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhalchandra Govind  | Managing Director | 18-May-1998 | Current |
| Manoj Israni | Managing Director | 05-Jan-1995 | Current |
| Suresh Mahalingam | Company Secretary | 14-Feb-2005 | Current |
| Ketki Wadhawa | CFO | 05-Jun-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Shirsat | Whole-Time Director | 01-Sep-2006 | Current |
| Rohit Patel | Director | 05-Dec-2007 | Current |
| Nihchal Israni | Director | 09-Jul-1980 | Current |
Satyanarain Agarwala  | Director | 17-Jan-2007 | Current |
| Rajendra Padhye | Director | 20-Mar-2001 | Current |
Financial Performance and Corporate Structure Insights of Blue Cross Laboratories.
Blue Cross Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.38% increase. The company also saw a slight improvement in profitability, with a 2.65% increase in profit. The company's net worth moved up by a moderate rise of 2.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Cross Laboratories?
In 2023, Blue Cross Laboratories had a promoter holding of 80.43% and a public holding of 19.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nihchal Israni FoundationActive 11 years 4 months
Manoj Israni, Nihchal Israni and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India (Lead Bank ) Creation Date: 07 Jan 1999 | ₹10.35 Cr | Satisfied |
How Many Employees Work at Blue Cross Laboratories?
Blue Cross Laboratories has a workforce of 2281 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Cross Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Cross Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
